Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 9:13 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2809–2832 of 145,445 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Disorder Clear all

Conditions: Nutrition, Diet Modification, Preventive Medicine, Cardiovascular Diseases, Health Promotion
Interventions: Diet Assessment Survey; Other
Lead sponsor: Penn State University; Other
Eligibility: 35 Years to 75 Years
Enrollment: 125 participants
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: University Park, Pennsylvania

Conditions: Major Depressive Disorder
Interventions: Cognitive Behavioral Therapy, Interpersonal Psychotherapy; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years to 65 Years
Enrollment: 77 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Breast Cancer, Anxiety, Pain
Interventions: Self-hypnotic Relaxation, Empathic Attention; Behavioral
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2004
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Autism Spectrum Disorder
Interventions: Tele-assessment + In-person assessment, Tele-assessment only; Behavioral
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 36 Months to 72 Months
Enrollment: 148 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Opiate Addiction
Interventions: Onsite treatment, Enhanced referral, Buprenorphine; Behavioral · Drug
Lead sponsor: Montefiore Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 97 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 3
States / cities: New York, New York • The Bronx, New York

Conditions: Breast Cancer
Interventions: denosumab, Surgery; Biological · Procedure
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years and older · Female only
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: New York, New York

Conditions: X-Linked Myotubular Myopathy
Interventions: Resamirigene bilparvovec; Genetic
Lead sponsor: Astellas Gene Therapies; Industry
Eligibility: Up to 5 Years · Male only
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2030
U.S. locations: 3
States / cities: Los Angeles, California • Chicago, Illinois • Bethesda, Maryland

Conditions: Extensive-stage Small Cell Lung Cancer
Interventions: Vorolanib, Atezolizumab; Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Renal Cell Carcinoma
Interventions: RAD001 and Sorafenib; Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 21 Years and older
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2014
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Cardiac Disease
Interventions: MyoVista wavECG Test; Device
Lead sponsor: Heart Test Laboratories, Inc.; Industry
Eligibility: 22 Years and older
Enrollment: 575 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 5
States / cities: La Jolla, California • Boston, Massachusetts • The Bronx, New York + 2 more

Conditions: Stroke
Interventions: Vibration Massage Therapy; Device
Lead sponsor: University of Oklahoma; Other
Eligibility: 18 Years and older
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Breast Cancer
Interventions: questionnaires, audio recordings , questionnaires, audio recorded questionnaires; Behavioral
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 21 Years and older · Female only
Enrollment: 85 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2015
U.S. locations: 3
States / cities: Commack, New York • New York, New York • Sleepy Hollow, New York

Conditions: Cervical Cancer
Interventions: BNI-brief Negotiated Interview; Behavioral
Lead sponsor: Boston Medical Center; Other
Eligibility: 11 Years to 15 Years · Female only
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Lung Cancer
Interventions: Erlotinib, Satraplatin; Drug
Lead sponsor: Agennix; Industry
Eligibility: 70 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 11
States / cities: Anaheim, California • La Jolla, California • Los Angeles, California + 8 more

Conditions: Androgenetic Alopecia
Interventions: Hemp Oil; Drug
Lead sponsor: Gregory L Smith, MD, MPH; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021
U.S. locations: 1
States / cities: Clearwater, Florida

Conditions: Restless Legs Syndrome
Interventions: Noctrix Health NPNS device v1.0 - Active, Noctrix Health NPNS device v1.0 - Sham; Device
Lead sponsor: Noctrix Health, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 43 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 3
States / cities: Downey, California • Menlo Park, California • San Ramon, California

Conditions: Severe Hypertriglyceridemia, Mixed Dyslipidaemia
Interventions: Gemcabene, Placebo; Drug
Lead sponsor: NeuroBo Pharmaceuticals Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 91 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 48
States / cities: Fort Payne, Alabama • Tucson, Arizona • Beverly Hills, California + 41 more

Conditions: Hypertension
Interventions: Remote Monitoring, Remote Monitoring + Social Support; Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 75 Years
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Cardiovascular Diseases
Interventions: TruGenome Cardiovascular Disease test; Diagnostic Test
Lead sponsor: Illumina, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 1,500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Down Syndrome
Interventions: Memantine, Placebo; Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 32 Years
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Obstructive Sleep Apnea
Interventions: blood biomarker; Diagnostic Test
Lead sponsor: Beckman Coulter, Inc.; Industry
Eligibility: 18 Years to 70 Years · Male only
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 3
States / cities: Irvine, California • Boston, Massachusetts • Columbia, South Carolina

Conditions: Acute Heart Failure, Renal Failure
Interventions: Not listed
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2016
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Diabetes Mellitus and Gastroparesis, Idiopathic Gastroparesis
Interventions: TAK-906 Maleate, Metaclopramide, TAK-906 Maleate Placebo; Drug
Lead sponsor: Millennium Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 51 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 9
States / cities: Peoria, Arizona • Tucson, Arizona • Little Rock, Arkansas + 5 more

Conditions: Melanoma, Non-small Sell Lung Cancer (NSCLC), Triple Negative Breast Cancer, Anaplastic Thyroid Cancer, Other Solid Tumors
Interventions: PDR001; Biological
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 319 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 6
States / cities: Baltimore, Maryland • Boston, Massachusetts • Portland, Oregon + 3 more

Search by objective public record fields.

Validation of a Diet Risk Screening Tool

Modeling Multi-level Dyadic Behavior to Transform the Science and Practice of Psychotherapy Process and Outcome.

Self Hypnotic Relaxation As An Adjunct To Local Anesthesia During Large Core Breast Biopsy

Can a Novel Telemedicine Tool Reduce Disparities Related to the Identification of Preschool Children With Autism?

Onsite Buprenorphine Treatment at Syringe Exchange Programs

Presurgical Trial of Denosumab in Breast Cancer

A Study of AT132 in Young Children With X-Linked Myotubular Myopathy (XLMTM)

Vorolanib + Atezolizumab as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer

Sorafenib and RAD001 Renal Cell Carcinoma

MyoVista wavECG Clinical Validation Study Versus Low e' on Echocardiogram

Evaluation of Vibration-based Wearable Upper Limb Rehabilitation Device

Physician-Patient Communication About Breast Cancer-Related Internet Information and Its Effect on Patient Satisfaction and Anxiety

An Intervention Study To Improve Human PapillomaVirus ( HPV) Immunization in Haitian and African American Girls

A Study Comparing Sequential Satraplatin & Erlotinib to Erlotinib in Unresectable Stage 3/4 Non-small-cell Lung Cancer (NSCLC)

Androgenetic Alopecia Treatment Using Varin and Cannabidiol Rich Topical Hemp Oil: A Case Series

Noninvasive Peripheral Nerve Stimulation for Restless Legs Syndrome

A 12-Week Study to Assess the Efficacy Safety and Tolerability of Gemcabene in Subjects With Severe Hypertriglyceridemia

Remote Monitoring and Social Support for Hypertension Management

CardioSeq: Impact of WGS in Individuals With CVD

Efficacy and Safety of Memantine Hydrochloride in Enhancing the Cognitive Abilities of Young Adults With Down Syndrome

Use of Blood Biomarkers and Biomarker Index to Aid in the Diagnosis of Obstructive Sleep Apnea (OSA)

Sequential Cystatin C Levels and Renal Impairment in Acute Heart Failure

A Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) for TAK-906 in Participants With Diabetes Mellitus and Gastroparesis (DG) or With Idiopathic Gastroparesis (IG)

Phase I/II Study of PDR001 in Patients With Advanced Malignancies